Awarded
1. Bevacizumab Intravenoso
Track this recordFree account — get alerted when a contract here runs out.
- Winners
- AMGEN S.A., BIOCON BIOLOGICS SPAIN S.L., Celltrion Farmaceutica España SL, CIPLA EUROPE NV Sucursal en España, LABORATORIO STADA SL, ORGANON SALUD, S.L., PFIZERSLU
- Contract value
- no value published
- Bids received
- 7
- Published
- 5 Jun 2026
- Awarded
- 29 May 2026
- Contract start
- 29 May 2026
- Contract end
- 30 May 2027estimated
- Region
- Tenerife